Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
An insufficiency and exocrine technology, applied in drug combination, endocrine system diseases, drug delivery, etc., can solve problems such as interference with proteolytic enzyme and amylolytic enzyme activity, lipolysis activity, etc., and achieve the effect of improving the quality of life
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0074] The present disclosure provides nutritional compositions wherein at least a portion of the macronutrients are in predigested form and / or in a form that does not require the use of pancreatic enzymes for digestion. Preferably, the composition has total protein consisting essentially of hydrolyzed protein and total fat comprising at least about 30% by weight monoacylglycerol (MAG) of the total fat, and optionally the total fat further comprising Medium Chain Triglycerides (MCT) and / or Fatty Acids. Optionally, at least a portion of the hydrolyzed protein may be substantially hydrolyzed protein.
[0075] In one embodiment, MAG can provide all of the fatty acids present in an edible oil (eg, soybean oil) in order to deliver effective amounts of essential fatty acids. Furthermore, in this regard, the fat source of the compositions disclosed herein is formulated to provide the patient with the necessary lipids, including all essential fatty acids, and to provide the lipids in...
Embodiment 1
[0126] Element
Embodiment 2
[0128]
[0129]
PUM
| Property | Measurement | Unit |
|---|---|---|
| Energy density | aaaaa | aaaaa |
| Energy density | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


